Pan-Cancer Analysis Based on <i>EPOR</i> Expression With Potential Value in Prognosis and Tumor Immunity in 33 Tumors.

Zhang, Yajing; Wang, Senyu; Han, Songtao; Feng, Yangchun

Pan-Cancer Analysis Based on EPOR Expression With Potential Value in Prognosis and Tumor Immunity in 33 Tumors.

Zhang, Yajing; Wang, Senyu; Han, Songtao; Feng, Yangchun.

Afiliación

Zhang Y; Clinical Laboratory Center, Cancer Hospital Affiliated to Xinjiang Medical University, Xinjiang, China.
Wang S; Xinjiang Key Laboratory of Oncology, Cancer Hospital Affiliated to Xinjiang Medical University, Xinjiang, China.
Han S; Xinjiang Key Laboratory of Oncology, Cancer Hospital Affiliated to Xinjiang Medical University, Xinjiang, China.
Feng Y; Clinical Laboratory Center, The Second Hospital Affiliated to Xinjiang Medical University, Xinjiang, China.

Front Oncol ; 12: 844794, 2022.

Article en En | MEDLINE | ID: mdl-35359375

Palabras clave

erythropoietin receptor; expression; pan-cancer; prognosis; tumor immunity

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Tipo de estudio: Prognostic_studies Idioma: En Revista: Front Oncol Año: 2022 Tipo del documento: Article País de afiliación: China Pais de publicación: Suiza

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google